ArticleBMC oral health2025
Clinical outcomes and prognostic factors in multiple primary malignancies involving oral cancer.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe incidence of multiple primary oral cancers (MPOCs) is rising, presenting significant diagnostic and treatment challenges and often resulting in poor prognosis. However, most research focuses on cases where all primary tumors originate within the oral cavity, with limited attention to scenarios where oral cancer arises as a second primary after initial tumors in other parts of the body. This study examines the clinical characteristics and prognosis in both scenarios.
methodsA retrospective review of 165 patients at the Affiliated Stomatological Hospital of Sun Yat-sen University identified 75 oral cancer first (OCF) cases and 90 non-oral cancer first (N-OCF) cases. We conducted a comparative analysis of clinical characteristics and prognosis between the two groups.
resultsMPOCs were more common in males, with an average age of 59.4 years, primarily presenting as early-stage squamous cell carcinoma (SCC), with the tongue as the most frequent site for secondary primary cancer (SPC). In the OCF group, the most common site for the first primary cancers (FPC) was also the tongue, whereas in the N-OCF group, it was the nasopharynx. Survival rates were comparable between the two groups, with key prognostic factors including age(p = 0.015), SPC T stage(p = 0.003), cervical lymph node metastasis of SPC(p = 0.021), and recurrence after SPC(p = 0.020).
conclusionsPatients with a history of nasopharyngeal cancer require long-term oral follow-up. While the location of FPC and SPC does not impact prognosis, early diagnosis and treatment significantly improve outcomes by enabling timely intervention before tumors advance or metastasize. Effective management of OPMDs is crucial for improving outcomes in MPOCs patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.